Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Persistent polyclonal B-cell lymphocytosis

S Agrawal1, E Matutes, J Voke

  • 1Academic Department of Haematology and Cytogenetics, Royal Marsden Hospital, London, U.K.

Leukemia Research
|October 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clustering of missense mutations in the ataxia-telangiectasia gene in a sporadic T-cell leukaemia.

Nature genetics·1997
Same author

The human T-cell lymphotropic viruses types I/II are not involved in T prolymphocytic leukemia and large granular lymphocytic leukemia.

Leukemia·1997
Same author

The significance of minimal residual disease in hairy cell leukaemia treated with deoxycoformycin: a long-term follow-up study.

British journal of haematology·1997
Same author

G-CSF mobilization of haemopoietic cell populations in SCID mice engrafted with human leukaemia.

Bone marrow transplantation·1997
Same author

Sezary cell leukaemia: a distinct T cell disorder or a variant form of T prolymphocytic leukaemia?

Leukemia·1997
Same author

Treatment of T-cell prolymphocytic leukemia with human CD52 antibody.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1997
Same journal

A multicenter real-world study of clinical outcomes in octogenarians and older patients with acute myeloid leukemia.

Leukemia research·2026
Same journal

FLAMSA versus FLAG-IDA as salvage therapy in adults with relapsed/refractory acute myeloid leukemia and acute lymphoblastic leukemia: A single-center real-world retrospective study.

Leukemia research·2026
Same journal

CD244 modulates bone marrow infiltrating CD8<sup>+</sup> T cells and serves as a prognostic and immunotherapeutic target in acute myeloid leukemia.

Leukemia research·2026
Same journal

Long-term remission and survival in older adults with IDH-mutated acute myeloid leukemia treated with IDH inhibitors.

Leukemia research·2026
Same journal

Real-world outcomes of plasmablastic lymphoma: Treatment approaches and survival outcomes in the PLASMABLAT-001 cohort.

Leukemia research·2026
Same journal

CRS and ICANS as class-level adverse event for CD20 ×CD3 bispecific T-cell engagers: A Bayesian analysis of a nationwide database.

Leukemia research·2026
See all related articles

Persistent polyclonal B-cell lymphocytosis involves benign B-cells, not a clonal cancer. This rare condition is linked to specific genetic markers and lifestyle factors in women.

Area of Science:

  • Hematology
  • Immunology
  • Genetics

Background:

  • Persistent polyclonal B-cell lymphocytosis (PPBCL) is a rare lymphoproliferative disorder.
  • Characterized by persistent lymphocytosis with distinctive morphological features.

Observation:

  • The case presented with characteristic binucleated circulating lymphocytes.
  • Immunological studies confirmed these lymphocytes were polyclonal B-cells.

Findings:

  • Cytogenetic and molecular analyses did not reveal a clonal B-cell population, supporting a non-malignant etiology.
  • Literature review identified associations with female sex, HLA-DR7, smoking, and elevated IgM levels, all present in this patient.

Implications:

  • This case reinforces the understanding of PPBCL as a benign condition.

Related Experiment Videos

  • Highlights the importance of immunological and genetic analysis in differentiating PPBCL from lymphoid malignancies.
  • Suggests potential etiological factors and risk associations for PPBCL.